Patent Assignment
Reel/Frame 060314/0745
Change of Name
Recorded: 2022-06-08
Pages: 3
Assignor
ZENITH EPIGENETICS CORP.
Executed: 2016-08-01
Assignee
ZENITH CAPITAL CORP.
300, 4820 RICHARD ROAD, SW, CALGARY, ALBERTA, T3E 6L1, CANADA
Covered Property
(1)
Novel Bicyclic Bromodomain Inhibitors
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 8, 2022
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: RVX THERAPEUTICS INC.
Reel/Frame 060141/0182 →
Assignment of Assignor's Interest
Jun 8, 2022
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 060141/0204 →
Assignment of Assignor's Interest
Jun 8, 2022
From: QUINN, JOHN FREDERICK; WAGNER, GREGORY STEVEN; DUFFY, BRYAN CORDELL; LIU, SHUANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 060314/0739 →
Assignment of Assignor's Interest
Jun 8, 2022
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 060314/0756 →